not seek treatment. Untreated chlamydial infection can persist for a year or more, leading to sustained risks of transmission. 6 In 1988, the New York State Department of Health's Bureau of Sexually Transmitted Disease (STD) Control initiated a screening program to assess the prevalence of chlamydial infection among women attending public health clinics throughout the state. In this article, we use data from this program to assess the reliability of established self-reported risk factors as a means to identify women with chlamydia infection and to identify factors that would facilitate selective screening.
Methodology

Program Sites and Population
Initial testing under the state program was conducted at 31 family planning sites between June 1988 and December 1989. In all of these clinics, the decision to test women was based on their responses to a questionnaire asking about the presence of eight factors that are associated with chlamydia: 7 whether they had come to the clinic for gonorrhea testing, had had unprotected sex within the past three months, were using the pill, had genital symptoms (discharge, lower abdominal pain or pain on urination), were pregnant,* had had more than one sexual partner in the past three months, had been informed by their partner of possible infection or had had an abnormal Pap smear within the past year. 1 For women, complications from chlamydia may lead to serious reproductive and infectious conditions, including pelvic inflammatory disease, ectopic pregnancy and infertility.
2 Some 50-70% of infected women who have a vaginal delivery pass the infection on to their infants, who then are at risk for neonatal conjunctivitis or pneumonia. 3 The risk of human immunodeficiency virus seroconversion among women with chlamydia is 3-5 times that among women who are not infected. 4 Total costs (direct and indirect) associated with chlamydia infections exceed $2.4 billion; roughly 80% of these costs are associated with infection in women. 5 However, the infection is often asymptomatic in women and therefore difficult to identify except through screening. Thus, about 50% of infected women may Women who reported any of these risk factors were tested.
To validate the use of these questions as criteria for selective screening for chlamydia, staff members at one clinic in northeastern New York (Clinic A) both administered the questionnaire and tested all women making an initial or annual visit (visits that included a routine pelvic examination), as well as those who came in with complaints of genital symptoms. Women from Clinic A are the only ones from the 1988-1989 testing to be included in this analysis. Clinical signs of infection-namely, cervical abnormalities † and moderate to heavy vaginal or cervical discharge-were also assessed, and women were classified according to whether or not they had such signs.
To test the reliability of the questionnaire across populations with varying prevalence rates and demographic profiles, the Bureau of STD Control conducted further chlamydia testing at three family planning clinics in southeastern New York (Clinics B-D) between June 1992 and December 1993. Women attending these clinics were tested at their initial and annual visits or if they had genital symptoms.
Data and Analyses
Some 1-5% of test results in the various clinics were categorized as "suspicious" ‡ or were based on unsatisfactory speci- variate analysis into a stepwise logistic regression. 8 The analyses are based on women for whom all variables were known (83-94% in each clinic); since these subgroups contained 85-94% of infected women, this restriction does not substantially affect the results.
Results
Women's Characteristics
The demographic characteristics of the 8,920 women screened varied somewhat by clinic (Table 1) . Clinic A had the largest proportion of clients who were teenagers (27% vs. 20-22%) and the smallest proportion who were aged 25 or older (27% vs. 41-47%). Clinics A and D served predominantly mens; these results were eliminated from the analyses. In addition, since no more than 2% of women in any clinic were pregnant at the time of the visit, this risk factor was eliminated. For the 1992-1993 data, if a woman made multiple visits to the clinic, only data for the first visit were included.
In univariate analyses, we used the chisquare statistic with continuity correction and, when appropriate, Fisher's exact test to identify variables that are significantly associated (at the 5% level) with chlamydial infection. To determine which factors are independently predictive of chlamydial infection, we entered variables that were statistically significant in the uniwhite women (94% and 85%, respectively), and Clinic B served mostly black women (70%). In Clinic C, women were more evenly divided by race or ethnicity.
Some 80-87% of the women had at least one risk factor for chlamydia. While 29-49% reported having engaged in unprotected intercourse within the previous three months, only 7-14% said they had had more than one sex partner during that time.
On the other hand, the absence of risk factors was also notable in some instances. No genital symptoms were present in 55-77% of the women, and 66-84% had not had an abnormal Pap smear within the past year.
Correlates of Infection
The prevalence of chlamydial infection was 7% in Clinic A, 6% in Clinic B, 4% in Clinic C and 2% in Clinic D. The rate of infection ranged from 2% to 8% among women who had any risk factors and from 2% to 5% among those who had none. Women reporting a risk factor almost always had a higher rate of infection than those without the same characteristic; the most obvious differences were noted in factors pertaining to risky behavior (unprotected intercourse and multiple partners) and STD-related clinic visits (gonorrhea treatment and infected partner).
Results of the univariate analysis showed that in the three clinics with rates of 4% or higher, women younger than 25 had a significantly elevated risk of infection: Those aged 20-24 had about triple the risk of older women, while women aged 13-19 had 4-7 times the risk. Odds ratios for the variables measured on the questionnaire were generally greater than 1.0, but most were not statistically significant.
Findings from the multivariate analysis (Table 2) did not vary remarkably from the univariate results. Age remained the most significant factor, and the magnitude of risk was roughly the same as in the univariate results. Race or ethnicity had the strongest influence in Clinic D, where nonwhite women were 3-5 times as likely as whites to be infected.
A few items that had been significant in the univariate analysis were no longer significant in the multivariate analysis-unprotected intercourse in Clinic D, multiple sex partners in Clinic B and abnormal Pap smear in Clinic A. The self-reported risk factors that remained significant had moderate effects, roughly doubling the risk.
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Discussion
This study shows that selecting women for chlamydia testing on the basis of their self-reported risk factors is not a significant improvement over universal screening. Although using any of eight self-reported risk factors resulted in the identification of more than 87% of all positive cases, this required screening of more than 85% of our study population. By contrast, in the three clinics where prevalence was 4% or greater, screening women aged 26 or younger (62-80% of all women) would have identified approximately 90% of those with chlamydial infection. However, in Clinic D, where prevalence was only 2%, age was not a significantly better screening criterion than self-reported risk factors; in cases like this, using some combination of selected risk factors (if these are known), clinical signs and age might be the most cost-effective method of selecting women for testing.
dia. In all, 64% of women visiting the clinic had no clinical signs, and 44% of the 315 infected women at this site were identified in this group. Among women with no clinical signs, those seeking gonorrhea treatment and those who had had more than one sex partner in the past three months had a slightly increased risk of infection, but those younger than 25 were at considerable risk. Teenagers had 3.6 times the risk of women aged 25 and older, and those in their early 20s had 2.3 times the risk. Table 3 shows the proportion of all clients who would need to be tested for chlamydia and the proportion of infected women who would be identified by using different screening criteria. With the Bureau of STD Control's method (testing all women with at least one risk factor), 80-87% of women would be screened, and approximately 90% of those infected would be identified. However, in Clinics A, B and C, using age as the only criterion, the testing of smaller proportions of women would identify even higher proportions of those with chlamydia. For example, in these three clinics, if all women aged 26 and younger (62-80% of the clinic population) were screened, 90-92% of infected women would be identified.
Evaluation of Screening Criteria
In Clinic D, where the prevalence rate was lower, age was not a good discriminant factor. Approximately 90% of infected women would be identified only by including all those younger than 30, which would require testing nearly 83% of the clinic population.
The data from Clinic A show that regardless of the presence or absence of clinical signs, if all women aged 25 or younger were screened, 75% of clients would be tested and about 90% of infected women would be identified (Figure 1, page 166) .
Our study has several limitations. Although the findings from Clinic A showed that more than 90% of infected women were identified when screening was restricted to those aged 25 or younger, regardless of clinical status, information on clinical signs of infection was not obtained from the other three clinics. Another limitation was the possibility that the prevalence of risk factors and risk-related behavior may have changed since the initial data were obtained. For example, condom use may have increased since 1989 because of concerns about infection with the human immunodeficiency virus.
The New York State family planning program offers STD services through 59 providers with 193 clinic sites statewide. During 1995, approximately 560,000 clinic visits were made by women, and about 150,000 tests for chlamydia were conducted. According to one laboratory report, which included test results from more than half of family planning clinics in 1995, the chlamydia prevalence rate was 3% overall, but 2% or lower at many clinics. 9 This raised the question of what recommendations for testing should be set for such clinics.
Several studies have established the validity of risk factors for targeting populations with C. trachomatis infection, especially where prevalence is low.
10 Although some studies have concluded that universal screening would be cost-effective in populations with a chlamydia prevalence of 2% or more, 11 screening programs in public health clinics are constrained by available funding, and limited resources must continue to be applied where they will be able to detect and treat as much infection as possible. For instance, re- searchers who modified screening criteria recommended by the Centers for Disease Control and Prevention on the basis of the characteristics of their population screened 64% of clients and identified 92% of infected women. 12 Although further studies are needed to evaluate more effective screening criteria in clinics where the prevalence of infection is low, this study shows that effective screening criteria based on risk factors that tend to be present in one clinic population may not be effective screening criteria in other populations. Family Planning Perspectives Screening Criteria for Chlamydia trachomatis Women with no clinical signs %
